| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Apr1g0113 | ATGCATTTAAGGAGCAGAATCACTCTCCAAAATAAAGTCTCTACAGTGAACACTATGAGTGAAGGTCTTCAAAAAACTGCTACCAACGGCCACGAGAAAATGTTAATATCACAAGAACAGCAGGCAATGATCAGTGAGATGCGAAGGTTGATAGGGCCGTTATCAGATAGGGCATCTCTGTATTGTTCTGATGCAACCATCTTAAGATATTTAAGCTCGCGAAATTGGAATGTCAAGAAAGCAGCTCAAATGTTGAAACACAGCCTAAAATGGAGAAAAGAATGCAAACCTGAAGAGATCCGCTGGGAAGAGGTTATTAATGAAGCAGAGACAGGGGTAATGTATAGAACAAATTATTGTGACAAGTATGGGAGACCAGTGATCGTAATGAGACCTTGTCGCCAGAACTCAAAGTCACTAAAAGGACAGATGAACTATTTTGTATACTGCATGGAGAATGCGATTTTGAATCTTCCAGCACACCAGGAGCAGGTGGTCTGGCTGATTGATTTCCACGGTTTCAATTTGTCACATGTATCATTCAAGGTGGCACGTGAAACTGCCCGAATACTACAAGAGCATTATCCAAAGCGCCTGGGTTTGGCAATACTCTACAATCCACCGGCAATCTTCCAACCATTCTTCGCGATGGTAAAGCCCTTTTTAGAGTCTGAGACCTATAATAGAGTAAAGTTTGGTTACTCCGACGATCCCAACACAAAGAAGATTATGGAGGATTTGTTTAATATGGATAATCTTGAATCTGCATTTGGTGGGAATGGTGGCACAGGAGTTGACAAAATTAAATATGCTGAGAGAATGAAAGAGGAAGACAATAAGACACGTTCGTTCTGGACACGTGCAAACTCTCTGTCATCAGTCTCACAAAATGCAGATTCTGATGCTTCTAATGTCGAGAAAATAGACCGTTCCCCTGTTCCTAACTGA | 948 | 0.4146 | MHLRSRITLQNKVSTVNTMSEGLQKTATNGHEKMLISQEQQAMISEMRRLIGPLSDRASLYCSDATILRYLSSRNWNVKKAAQMLKHSLKWRKECKPEEIRWEEVINEAETGVMYRTNYCDKYGRPVIVMRPCRQNSKSLKGQMNYFVYCMENAILNLPAHQEQVVWLIDFHGFNLSHVSFKVARETARILQEHYPKRLGLAILYNPPAIFQPFFAMVKPFLESETYNRVKFGYSDDPNTKKIMEDLFNMDNLESAFGGNGGTGVDKIKYAERMKEEDNKTRSFWTRANSLSSVSQNADSDASNVEKIDRSPVPN* | 316 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Apr1g0113 | 315 | Pfam | CRAL/TRIO domain | 112 | 259 | IPR001251 | - | |
| Apr1g0113 | 315 | PANTHER | GH16843P | 19 | 311 | - | - | |
| Apr1g0113 | 315 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 36 | 104 | IPR036273 | - | |
| Apr1g0113 | 315 | SMART | sec14_4 | 108 | 262 | IPR001251 | - | |
| Apr1g0113 | 315 | SMART | CRAL_TRIO_N_2 | 63 | 88 | IPR011074 | - | |
| Apr1g0113 | 315 | CDD | SEC14 | 103 | 260 | IPR001251 | - | |
| Apr1g0113 | 315 | MobiDBLite | consensus disorder prediction | 290 | 315 | - | - | |
| Apr1g0113 | 315 | Gene3D | - | 8 | 304 | IPR036865 | - | |
| Apr1g0113 | 315 | PANTHER | CRAL-TRIO LIPID BINDING DOMAIN, CRAL/TRIO DOMAIN-CONTAINING PROTEIN-RELATED | 19 | 311 | - | - | |
| Apr1g0113 | 315 | SUPERFAMILY | CRAL/TRIO domain | 102 | 280 | IPR036865 | - | |
| Apr1g0113 | 315 | PRINTS | Cellular retinaldehyde-binding protein signature | 66 | 88 | - | - | |
| Apr1g0113 | 315 | PRINTS | Cellular retinaldehyde-binding protein signature | 182 | 203 | - | - | |
| Apr1g0113 | 315 | PRINTS | Cellular retinaldehyde-binding protein signature | 215 | 234 | - | - | |
| Apr1g0113 | 315 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 102 | 259 | IPR001251 | - | |
| Apr1g0113 | 315 | Pfam | CRAL/TRIO, N-terminal domain | 46 | 86 | IPR011074 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Apr1g0113 | Apr-Chr1 | 1261065 | 1265062 | Dispersed/Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Apr1g0113 | 67 | 231 | Acyl Lipid Metabolism Gene Families | AT1G55840 | 23.404 | 1.62e-06 | 47.0 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Apr1g0113 | - | - | gmx:100777065 | 442.195 |